F Shimizu

1.5k total citations
54 papers, 1.3k citations indexed

About

F Shimizu is a scholar working on Nephrology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, F Shimizu has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Nephrology, 18 papers in Molecular Biology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in F Shimizu's work include Renal Diseases and Glomerulopathies (19 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Cell Adhesion Molecules Research (10 papers). F Shimizu is often cited by papers focused on Renal Diseases and Glomerulopathies (19 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Cell Adhesion Molecules Research (10 papers). F Shimizu collaborates with scholars based in Japan, Germany and United States. F Shimizu's co-authors include Takashi Oite, Michiaki Orikasa, K. Matsui, Hiroshi Kawachi, T. Morioka, Masanori Kitamura, Leon G. Fine, A Vogt, Toshihiko Iwanaga and Robert J. Unwin and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

F Shimizu

54 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Shimizu Japan 20 669 596 272 129 115 54 1.3k
Simone M. Blattner Germany 15 780 1.2× 513 0.9× 287 1.1× 182 1.4× 93 0.8× 19 1.5k
Abdalla Rifai United States 19 581 0.9× 426 0.7× 302 1.1× 82 0.6× 53 0.5× 31 1.3k
Gurjeet Bhangal United Kingdom 20 365 0.5× 401 0.7× 353 1.3× 59 0.5× 83 0.7× 32 1.2k
Y S Kanwar United States 15 251 0.4× 419 0.7× 216 0.8× 125 1.0× 92 0.8× 23 991
Stephen J. Klaus United States 16 160 0.2× 774 1.3× 647 2.4× 253 2.0× 44 0.4× 21 2.0k
Ulrich Sauer Germany 17 207 0.3× 560 0.9× 90 0.3× 76 0.6× 71 0.6× 22 1.1k
Antonella Capozzi Italy 22 108 0.2× 462 0.8× 348 1.3× 185 1.4× 153 1.3× 71 1.5k
Seiichiro Tarui Japan 17 62 0.1× 523 0.9× 375 1.4× 225 1.7× 112 1.0× 40 1.3k
Hongwen Zhang China 16 144 0.2× 366 0.6× 72 0.3× 98 0.8× 103 0.9× 67 731

Countries citing papers authored by F Shimizu

Since Specialization
Citations

This map shows the geographic impact of F Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Shimizu more than expected).

Fields of papers citing papers by F Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Shimizu. The network helps show where F Shimizu may publish in the future.

Co-authorship network of co-authors of F Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of F Shimizu. A scholar is included among the top collaborators of F Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Shimizu. F Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashimoto, Takeshi, Tamaki Karasawa, Akira Saito, et al.. (2007). Ephrin-B1 localizes at the slit diaphragm of the glomerular podocyte. Kidney International. 72(8). 954–964. 51 indexed citations
2.
Mizui, Masayuki, Yoshitaka Isaka, Yasufumi Sato, et al.. (2006). Transcription factor Ets-1 is essential for mesangial matrix remodeling. Kidney International. 70(2). 298–305. 25 indexed citations
3.
Hara, Akinori, Takashi Wada, Kengo Furuichi, et al.. (2006). Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney International. 69(11). 1986–1995. 82 indexed citations
4.
Monkawa, Toshiaki, Jun Yoshino, Masato Asai, et al.. (2006). Microarray analysis of a reversible model and an irreversible model of anti-Thy-1 nephritis. Kidney International. 69(6). 996–1004. 18 indexed citations
5.
Isaka, Yoshitaka, Masayuki Mizui, Hiroshi Kawachi, et al.. (2005). Exploring RNA interference as a therapeutic strategy for renal disease. Gene Therapy. 12(12). 965–973. 73 indexed citations
6.
Morioka, T., Kensuke Joh, F Shimizu, & Takashi Oite. (2000). Nucleosome core particles and DNA bind to the human glomerular basement membrane (GBM): role of the amyloid P component of the GBM. Clinical and Experimental Nephrology. 4(1). 43–48. 1 indexed citations
7.
Shimizu, F, Hiroshi Kawachi, & Michiaki Orikasa. (1999). Role of Mesangial Cell Damage in Progressive Renal Disease. Kidney & Blood Pressure Research. 22(1-2). 5–12. 15 indexed citations
8.
Nakayama, Hitoshi, Takashi Oite, Hiroshi Kawachi, et al.. (1998). Comparative Nephritogenicity of Two Monoclonal Antibodies That Recognize Different Epitopes ofRat Thy-1.1 Molecule. ˜The œNephron journals/Nephron journals. 78(4). 453–463. 24 indexed citations
9.
Nakamura, Takamichi, Jun–ei Obata, Masanari Onizuka, et al.. (1997). Candesartan prevents the progression of mesangioproliferative nephritis in rats.. PubMed. 63. S226–8. 10 indexed citations
10.
Sütö, Tamás, Leon G. Fine, F Shimizu, & Masanori Kitamura. (1997). In vivo transfer of engineered macrophages into the glomerulus: endogenous TGF-beta-mediated defense against macrophage-induced glomerular cell activation. The Journal of Immunology. 159(5). 2476–2483. 26 indexed citations
11.
Morita, Yoshiharu, Akihiro Nomura, Y. Yuzawa, et al.. (1997). The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis.. Journal of the American Society of Nephrology. 8(9). 1363–1372. 68 indexed citations
12.
Orikasa, Michiaki, et al.. (1995). Progressive renal lesions induced by administration of monoclonal antibody 1-22-3 to unilaterally nephrectomized rats. Clinical & Experimental Immunology. 102(1). 181–185. 49 indexed citations
13.
Kuroda, Takeshi, Keisuke Kawasaki, Takashi Oite, Masaaki Arakawa, & F Shimizu. (1994). Nephrotoxic Serum Nephritis in Nude Rats: The Role of Cell-Mediated Immunity. ˜The œNephron journals/Nephron journals. 68(3). 360–365. 9 indexed citations
14.
15.
Sato, Takehiro, T. Morioka, Takako Saeki, et al.. (1993). Nephrotoxic serum nephritis in nude rats: the roles of host immune reactions in the accelerated type. Clinical & Experimental Immunology. 91(1). 131–134. 2 indexed citations
16.
Kawachi, Hiroshi, Takashi Oite, & F Shimizu. (1993). Quantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1-22-3. Clinical & Experimental Immunology. 92(2). 342–346. 30 indexed citations
17.
Nakamura, Takamichi, Takashi Oite, Takashi Kazama, et al.. (1988). Monoclonal antibodies to human glomerular antigens. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 412(6). 573–582. 4 indexed citations
18.
Oite, Takashi, et al.. (1986). The effect of protamine sulfate on the course of immune complex glomerulonephritis in the rat.. PubMed. 64(2). 318–22. 4 indexed citations
19.
Hitomi, Masahiro & F Shimizu. (1985). Effects of mononuclear phagocyte system modulating agents on Fc and C3 receptors of adherent cells.. PubMed. 66(3). 371–6. 3 indexed citations
20.
Shimizu, F, Horst Mossmann, H. Takamiya, & A Vogt. (1978). Effect of antibody avidity on the induction of renal injury in anti-glomerular basement membrane nephritis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 59(6). 624–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026